Tudor Investment Corp
HGEN

Tudor Investment Corp’s HUMANIGEN, INC. HGEN Stock Holding History

Tudor Investment Corp’s Portfolio HGEN Stock Details HGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-11,679
Closed -$43K – 2842
2021
Q4 		$43K Buy
+11,679
New +$68.3K ﹤0.01% 2277

Other funds holding HGEN

VCM
Valiant Capital Management San Francisco, California $1.74B AUM 64.05% 1-Year Est. Return
M
Murchinson Toronto, Ontario, Canada $791M AUM 68.08% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Tudor Investment Corp's HGEN Position: Q1 2022 in Review

Tudor Investment Corp sold out of HUMANIGEN, INC. (HGEN) in Q1 2022, closing a stake of 11,679 shares — an estimated $43K sold.

Tudor Investment Corp first reported a position in HGEN in Q4 2021 and held it in 1 quarter. The position peaked at $43K in Q4 2021. 83 funds tracked by Wall St. Rank hold HGEN as of Q1 2022.

  • Tudor Investment Corp reported no remaining HUMANIGEN, INC. position as of Q1 2022 after selling out during the quarter.
  • Tudor Investment Corp sold 11,679 HUMANIGEN, INC. shares in Q1 2022, an estimated $43K.
  • Tudor Investment Corp first reported a position in HUMANIGEN, INC. in Q4 2021 and held it in 1 quarter.
  • Tudor Investment Corp's HUMANIGEN, INC. position peaked at $43K in Q4 2021.
  • 83 funds tracked by Wall St. Rank held HUMANIGEN, INC. as of Q1 2022.

Based on Tudor Investment Corp's 13F filing for Q1 2022, filed 16 May 2022.